Daniel Vitt
Directeur Général chez IMMUNIC, INC.
Fortune : 474 865 $ au 30/04/2024
Postes actifs de Daniel Vitt
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNIC, INC. | Directeur/Membre du Conseil | 01/01/2019 | - |
Directeur Général | 01/01/2017 | - | |
President | 01/01/2017 | - | |
Weltoffen-Germering Weltladen eG | Directeur/Membre du Conseil | 10/05/2010 | - |
4SC Discovery GmbH
4SC Discovery GmbH BiotechnologyHealth Technology 4SC Discovery GmbH provides research and development services in biology. The company is headquartered in Planegg-Martinsried, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2012 | - |
Directeur Général | 01/01/2012 | - | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Directeur/Membre du Conseil | - | - |
Directeur Général | 09/01/2017 | - | |
President | - | - | |
quattro research GmbH
quattro research GmbH Miscellaneous Commercial ServicesCommercial Services Quattro Research GmbH is an interdisciplinary team of scientists and IT professionals that provides IT solutions for research and development. The private company is based in Martinsried, Germany. The German company specializes in bioregistration and handles antibodies and other macromolecules. The company also offers products such as the HELM hierarchical editing language for macromolecules and an electronic lab journal. Quattro/CM is their software that helps manage inventory easily. | Directeur/Membre du Conseil | - | - |
Immunic Research GmbH | Directeur Général | - | - |
Brauhaus Germering GmbH | Directeur Général | 01/01/2018 | - |
Fondateur | 01/01/2018 | - | |
Listrax Ug | Directeur Général | - | - |
Historique de carrière de Daniel Vitt
Anciens postes connus de Daniel Vitt
Sociétés | Poste | Début | Fin |
---|---|---|---|
4SC AG | Directeur Technique/Scientifique/R&D | 10/05/2010 | 31/12/2016 |
Fondateur | 01/01/1997 | 31/12/2016 | |
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Daniel Vitt
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Statistiques
Internationale
Allemagne | 11 |
Etats-Unis | 3 |
Opérationnelle
Chief Executive Officer | 7 |
Director/Board Member | 6 |
President | 3 |
Sectorielle
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
4SC AG | Health Technology |
IMMUNIC, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Weltoffen-Germering Weltladen eG | |
4SC Discovery GmbH
4SC Discovery GmbH BiotechnologyHealth Technology 4SC Discovery GmbH provides research and development services in biology. The company is headquartered in Planegg-Martinsried, Germany. | Health Technology |
Nexigen GmbH
Nexigen GmbH Pharmaceuticals: MajorHealth Technology Nexigen GmbH identifies and develops peptide based therapeutics for cancer. It focuses on the development of pathways to create transformative cancer therapies. The firm's technologies give access to drug targets which pose significant challenges to conventional discovery approaches. The company was founded by Annette Friebe, Burckhard Heil, and Claudia Carl in 2007 and is headquartered in Cologne, Germany. | Health Technology |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
quattro research GmbH
quattro research GmbH Miscellaneous Commercial ServicesCommercial Services Quattro Research GmbH is an interdisciplinary team of scientists and IT professionals that provides IT solutions for research and development. The private company is based in Martinsried, Germany. The German company specializes in bioregistration and handles antibodies and other macromolecules. The company also offers products such as the HELM hierarchical editing language for macromolecules and an electronic lab journal. Quattro/CM is their software that helps manage inventory easily. | Commercial Services |
Immunic Research GmbH | |
Brauhaus Germering GmbH | |
Listrax Ug |
- Bourse
- Insiders
- Daniel Vitt
- Expérience